CMPS COMPASS Pathways Plc - American Depository Shares
$13,94
Prezzo · Ago 19, 2026
Fondamentali al Ago 5, 2026
Intervallo 52 sett.
$4–$15
87% of range
Rating Analisti
BUY
24 analysts
Prezzo Obiettivo
$24
+70% upside
P/E (TTM)
-4.5
ROE
-524.8%
Margine di Profitto Netto
—
Informazioni su COMPASS Pathways Plc - American Depository Shares Panoramica della società da Wikipedia
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
Leggi di più
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
Compass Pathways is the largest company in the psychedelic medicine industry and, in 2020, was the first psychedelic medicine company to be listed on the NASDAQ. It has faced criticism for patenting psychedelic drugs and even certain psilocybin mushroom species. In October 2024, after the FDA rejected Lykos Therapeutics's MDMA for post-traumatic stress disorder (PTSD) New Drug Application (NDA), Compass Pathways said that it would lay off 30% of its workforce and narrow its research focus.
Compass Pathways has entered partnerships with several independent psychedelic academic scientists, including Jason Wallach, Hamilton Morris, and Adam Halberstadt among others, to develop novel psychedelic drugs for potential medical use. Wallach's lab is said to have sought patents for over 200 novel compounds as of May 2024.
Compass Pathways switched from being a nonprofit organization to a for-profit company in 2016. The pharmaceutical company has been backed and funded by a number of tech entrepreneurs such as Peter Thiel. The media outlet Sifted remarks that the biotech billionaire Christian Angermayer was instrumental in the founding of Compass Pathways."
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
CMPS Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$13.94
Capitalizzazione di Mercato
$1.34B
P/E (TTM)
-4.5
EPS (TTM)
$-3.08
Ricavi (TTM)
—
Rendimento div.
—
ROE
-524.8%
D/E Debito/Patrimonio
-0.6
Intervallo 52 sett.
$4 – $15
CMPS Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
—
EPS
$-3.08
2019-12-31
→
2025-12-31
Flusso di cassa libero
—
2021-12-31
→
2024-12-31
Margini
—
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
CMPS
Mediana dei peer
P/E (TTM)
-4.5
66.9
P/B
-25.3
3.7
EV / EBITDA
-6.8
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
CMPS
Mediana dei peer
ROA
-135.8%
-23.9%
ROE
-524.8%
-27.7%
ROIC
836.7%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
CMPS
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
-0.6
4.4
Current Ratio (Rapporto corrente)
0.8
4.0
Quick Ratio
0.6
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
CMPS
Mediana dei peer
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
CMPS
Mediana dei peer
CMPS Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
24 analisti
- Acquisto forte 8 33,3%
- Compra 14 58,3%
- Mantieni 2 8,3%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
16 analisti · 2026-08-16
Mediana
$21.00
Ora
$13.94
Basso
$13.00
Alto
$65.00
Target mediano
$21.00
+50,6%
Target medio
$23.75
+70,4%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.27%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-1.88 | $-0.41 | -1.5% |
| 31 Marzo 2026 | $0.71 | $-0.39 | 1.1% |
| 31 Dicembre 2025 | $-1.00 | $-0.40 | -0.60% |
| 30 Settembre 2025 | $-1.44 | $-0.40 | -1.0% |
| 30 Giugno 2025 | $-0.41 | $-0.44 | 0.03% |
| 31 Marzo 2025 | $-0.38 | $-0.48 | 0.10% |
| 31 Dicembre 2024 | $-0.63 | $-0.64 | 0.01% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| CMPS | $663M | -2.2 | — | — | -524.8% | — |
| ROIV | $19.95B | -51.3 | -71.6% | -3629.2% | -6.5% | — |
| BDRX | — | — | — | — | — | — |
| KNSA | $3.15B | 55.0 | 60.1% | 8.7% | 11.1% | — |
| IMCR | $1.76B | -48.9 | 28.9% | -8.9% | -9.2% | — |
| AUTL | — | -1.8 | 644.9% | -381.4% | -109.6% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $118M | $119M | $88M | $65M | $44M | $23M | |
| SG&A Expense | $61M | $59M | $49M | $45M | $39M | $28M | |
| Operating Expenses | $179M | $178M | $137M | $110M | $83M | $51M | |
| Operating Income | $-179M | $-178M | $-137M | $-110M | $-83M | $-51M | |
| Interest Expense | · | · | $2M | $0 | $0 | · | |
| Interest Income | $7M | $8M | $5M | · | · | · | |
| Other Non-op | $1M | $823.0K | $255.0K | $19M | $12M | $-9M | |
| Pretax Income | $-290M | $-154M | $-118M | $-91M | $-72M | $-60M | |
| Income Tax | $-2M | $2M | $780.0K | $408.0K | $199.0K | $32.0K | |
| Net Income | $-288M | $-155M | $-118M | $-92M | $-72M | $-60M | |
| EPS (Basic) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| EPS (Diluted) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| Shares (Basic) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| Shares (Diluted) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| EBITDA | $-179M | $-178M | $-137M | $-110M | $-83M | · |
Stato Patrimoniale 22
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $150M | $165M | $220M | $143M | $273M | $190M | |
| Prepaid Expense | $42M | $36M | $41M | $48M | $22M | $12M | |
| Other Current Assets | $6M | $4M | $2M | $1M | $1M | $509.0K | |
| Current Assets | $191M | $201M | $261M | $192M | $295M | $202M | |
| PP&E (Net) | · | $189.0K | $423.0K | $617.0K | $398.0K | $245.0K | |
| PP&E (Gross) | · | · | · | $1M | $756.0K | $433.0K | |
| Accum. Depreciation | · | · | · | $530.0K | $358.0K | $188.0K | |
| Other Non-current Assets | $12M | $7M | $7M | $1M | $213.0K | $57.0K | |
| Total Assets | $210M | $214M | $276M | $197M | $301M | $203M | |
| Accounts Payable | $15M | $12M | $6M | $5M | $3M | $3M | |
| Current Liabilities | $248M | $34M | $20M | $16M | $15M | $7M | |
| Capital Leases | $1M | $303.0K | $2M | $418.0K | $1M | · | |
| Total Liabilities | $263M | $59M | $50M | $16M | $16M | $7M | |
| Long-term Debt | $32M | $30M | $29M | $0 | · | · | |
| Total Debt | $32M | $30M | · | · | · | · | |
| Common Stock | $973.0K | $702.0K | $635.0K | · | · | · | |
| Paid-in Capital | $784M | $705M | $622M | $459M | $445M | $279M | |
| Retained Earnings | $-823M | $-535M | $-380M | $-261M | $-170M | $-98M | |
| AOCI | $-15M | $-16M | $-17M | $-17M | $9M | $15M | |
| Stockholders' Equity | $-53M | $155M | $226M | $181M | $284M | $197M | |
| Liabilities + Equity | $210M | $214M | $276M | $197M | $301M | $203M | |
| Shares Outstanding | 96,085,785 | 68,552,215 | 61,943,471 | · | · | · |
Flusso di cassa 16
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | $242.0K | $330.0K | $175.0K | $112.0K | |
| Stock-based Comp | $14M | $20M | $17M | $13M | $9M | $18M | |
| Deferred Tax | $22.0K | $-437.0K | $-1M | $-1M | $-545.0K | $-221.0K | |
| Other Non-cash | · | · | $5M | $-26M | $-4M | · | |
| Operating Cash Flow | $-157M | $-119M | $-97M | $-105M | $-68M | $-41M | |
| CapEx | · | $0 | $66.0K | $596.0K | $334.0K | $131.0K | |
| Investing Cash Flow | · | $0 | $-64.0K | $-596.0K | $-334.0K | $-628.0K | |
| Debt Issued | · | $0 | $30M | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $30M | · | · | · | |
| Stock Issued | $140M | $26M | $145M | $440.0K | $155M | $0 | |
| Net Stock Activity | $140M | $26M | $145M | $440.0K | $155M | · | |
| Financing Cash Flow | $141M | $64M | $174M | $1M | $157M | $194M | |
| Net Change in Cash | $-15M | $-55M | $77M | $-130M | $83M | $165M | |
| Taxes Paid | $755.0K | · | · | · | · | · | |
| Free Cash Flow | · | $-119M | $-97M | $-106M | $-68M | · | |
| Levered FCF | · | · | $-100M | · | · | · |
Redditività 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -135.8% | -63.4% | -50.1% | -36.7% | -28.4% | · | |
| ROE | -524.8% | -89.2% | -49.5% | -48.7% | -24.3% | · | |
| ROIC | 836.7% | -97.4% | -61.1% | -61.2% | -29.3% | · |
Liquidità e Solvibilità 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 | · | |
| Quick Ratio | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 | · | |
| Debt / Equity | -0.6 | 0.2 | · | · | · | · | |
| LT Debt / Equity | -0.3 | 0.2 | · | · | · | · | |
| Interest Coverage | · | · | -62.1 | · | · | · |
Valutazione (TTM) 11
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-288M | $-155M | $-118M | $-92M | $-72M | · | |
| Market Cap | $663M | $259M | · | · | · | · | |
| Enterprise Value | $545M | $124M | · | · | · | · | |
| P/E | -2.2 | -1.6 | -3.8 | -3.7 | -12.3 | · | |
| P/B | -12.5 | 1.7 | · | · | · | · | |
| P / Tangible Book | · | 1.7 | · | · | · | · | |
| P / Cash Flow | -4.2 | -2.2 | · | · | · | · | |
| P / FCF | · | -2.2 | · | · | · | · | |
| EV / EBITDA | -3.0 | -0.7 | · | · | · | · | |
| EV / FCF | · | -1.0 | · | · | · | · | |
| Earnings Yield | -44.6% | -60.9% | -26.5% | -26.9% | -8.1% | · |
Conto Economico 15
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $26M | $30M | $27M | $30M | $31M | $32M | $33M | $29M | $25M | $27M | $22M | $20M | $19M | $20M | $14M | |
| SG&A Expense | $23M | $16M | $16M | $13M | $13M | $19M | $16M | $15M | $14M | $14M | $11M | $13M | $13M | $13M | $12M | $12M | |
| Operating Expenses | $52M | $43M | $46M | $41M | $43M | $50M | $48M | $48M | $43M | $39M | $38M | $34M | $33M | $32M | $32M | $26M | |
| Operating Income | $-52M | $-43M | $-46M | $-41M | $-43M | $-50M | $-48M | $-48M | $-43M | $-39M | $-38M | $-34M | $-33M | $-32M | $-32M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | · | $0 | $0 | $0 | |
| Interest Income | $4M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $638.0K | · | · | · | |
| Other Non-op | $546.0K | $484.0K | $370.0K | $383.0K | $-176.0K | $803.0K | $337.0K | $191.0K | $167.0K | $128.0K | $-8M | $112.0K | $-11.0K | $8M | $1M | $7M | |
| Pretax Income | $-253M | $91M | $-97M | $-138M | $-38M | $-18M | $-42M | $-38M | $-38M | $-35M | $-32M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| Income Tax | $331.0K | $-11.0K | $-3M | $-230.0K | $137.0K | $354.0K | $1M | $173.0K | $176.0K | $222.0K | $394.0K | $62.0K | $194.0K | $130.0K | $92.0K | $120.0K | |
| Net Income | $-254M | $91M | $-94M | $-138M | $-38M | $-18M | $-43M | $-39M | $-38M | $-35M | $-33M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| EPS (Basic) | $-1.88 | $0.71 | $-1.03 | $-1.44 | $-0.41 | $-0.20 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| EPS (Diluted) | $-1.88 | $-0.30 | $-0.99 | $-1.44 | $-0.41 | $-0.24 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| Shares (Basic) | 135,039,810 | 110,064,581 | -184,367,003 | 95,337,993 | 93,341,594 | 89,192,252 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| Shares (Diluted) | 135,039,810 | 130,266,693 | -193,816,374 | 95,337,993 | 93,341,594 | 98,641,623 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| EBITDA | $-52M | $-43M | · | $-41M | $-43M | $-50M | · | $-48M | $-43M | $-39M | · | $-34M | $-33M | $-32M | · | $-25M |
Stato Patrimoniale 22
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $433M | $466M | $150M | $186M | $222M | $260M | $165M | $207M | $229M | $263M | $220M | $248M | $148M | $117M | $143M | $173M | |
| Prepaid Expense | $42M | $44M | $42M | $56M | $54M | $45M | $36M | $26M | $36M | $31M | $41M | $36M | $45M | $50M | $48M | $45M | |
| Other Current Assets | $8M | $7M | $6M | $3M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Current Assets | $476M | $511M | $191M | $242M | $276M | $305M | $201M | $234M | $265M | $296M | $261M | $285M | $194M | $168M | $192M | $218M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | $359.0K | $423.0K | $309.0K | $482.0K | $612.0K | $617.0K | $555.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $950.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $395.0K | |
| Other Non-current Assets | $20M | $14M | $12M | $5M | $9M | $8M | $7M | $7M | $6M | $6M | $7M | $6M | $7M | $212.0K | $1M | $299.0K | |
| Total Assets | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Accounts Payable | $12M | $11M | $15M | $5M | $11M | $9M | $12M | $8M | $8M | $9M | $6M | $4M | $2M | $4M | $5M | $20M | |
| Current Liabilities | $367M | $154M | $248M | $197M | $31M | $30M | $34M | $26M | $22M | $19M | $20M | $15M | $13M | $11M | $16M | $30M | |
| Capital Leases | $2M | $779.0K | $1M | $2M | $2M | $259.0K | $303.0K | $459.0K | $799.0K | $1M | $2M | $2M | $3M | $412.0K | $418.0K | $425.0K | |
| Total Liabilities | $420M | $205M | $263M | $218M | $131M | $124M | $59M | $54M | $52M | $50M | $50M | $46M | $43M | $12M | $16M | $30M | |
| Long-term Debt | $51M | $50M | $32M | $31M | $31M | $31M | $30M | $30M | $29M | $29M | $29M | $28M | $28M | · | $0 | · | |
| Total Debt | $51M | $50M | · | $31M | $31M | $31M | · | $28M | · | · | · | · | · | · | · | · | |
| Common Stock | $1M | $1M | $973.0K | $973.0K | $946.0K | $938.0K | $702.0K | $699.0K | $699.0K | $699.0K | $635.0K | · | · | · | · | · | |
| Paid-in Capital | $1.08B | $1.07B | $784M | $781M | $767M | $763M | $705M | $700M | $695M | $690M | $622M | $617M | $496M | $464M | $459M | $455M | |
| Retained Earnings | $-985M | $-731M | $-823M | $-729M | $-591M | $-553M | $-535M | $-491M | $-453M | $-415M | $-380M | $-347M | $-314M | $-285M | $-261M | $-230M | |
| AOCI | $-15M | $-15M | $-15M | $-15M | $-15M | $-16M | $-16M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-31M | |
| Stockholders' Equity | $85M | $327M | $-53M | $38M | $163M | $195M | $155M | $193M | $226M | $259M | $226M | $253M | $166M | $162M | $181M | $195M | |
| Liabilities + Equity | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Shares Outstanding | 135,722,306 | 134,923,295 | 96,085,785 | 96,002,044 | 93,586,348 | 92,848,326 | 68,552,215 | 68,409,068 | 68,387,469 | 68,342,534 | 61,943,471 | · | · | · | · | · |
Flusso di cassa 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $59.0K | $63.0K | $61.0K | · | $186.0K | $110.0K | $48.0K | $76.0K | $100.0K | |
| Stock-based Comp | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | $4M | $5M | $4M | $3M | $4M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $9M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $-40M | $-48M | $-38M | $-35M | $-39M | $-46M | $-42M | $-22M | $-34M | $-21M | $-28M | $-17M | $-25M | $-28M | $-45M | $-19M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $18.0K | $19.0K | $29.0K | $107.0K | $-5.0K | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-18.0K | $-17.0K | $-29.0K | $-107.0K | $5.0K | |
| Debt Issued | $0 | $19M | · | · | $0 | $0 | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Debt Issued | · | $19M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | $141M | $0 | $0 | $0 | $140M | $0 | $0 | $0 | $26M | $-41.0K | $117M | $27M | $1M | $440.0K | $0 | |
| Net Stock Activity | · | $141M | · | · | · | $140M | · | · | · | $26M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $8M | $362M | $187.0K | $0 | $166.0K | $140M | $155.0K | $-53.0K | $210.0K | $64M | $41.0K | $117M | $56M | $1M | $639.0K | $-1.0K | |
| Net Change in Cash | $-33M | $316M | $-36M | $-36M | $-38M | $95M | $-42M | $-22M | $-34M | $43M | $-28M | $100M | $31M | $-26M | $-30M | $-34M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-21M | · | · | · | $-28M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-22M | · | · | · | · | · | · |
Redditività 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -63.6% | 21.4% | · | -54.8% | -13.4% | -5.7% | · | -14.1% | -15.6% | -14.6% | · | -12.8% | -12.6% | -10.9% | · | -16.4% | |
| ROE | -205.4% | 34.9% | · | -119.4% | -19.8% | -7.9% | · | -17.2% | -19.4% | -16.7% | · | -14.9% | -14.5% | -11.5% | · | -18.9% | |
| ROIC | -38.8% | -11.4% | · | -58.8% | -22.3% | -22.4% | · | -21.8% | -19.2% | -15.0% | · | -13.5% | -19.8% | -19.8% | · | -13.2% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 3.3 | · | 1.2 | 8.8 | 10.2 | · | 8.9 | 12.0 | 15.2 | · | 18.6 | 15.2 | 14.9 | · | 7.4 | |
| Quick Ratio | 1.2 | 3.0 | · | 0.9 | 7.1 | 8.7 | · | 7.9 | 10.4 | 13.5 | · | 16.2 | 11.6 | 10.4 | · | 5.9 | |
| Debt / Equity | 0.6 | 0.2 | · | 0.8 | 0.2 | 0.2 | · | 0.1 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.2 | · | 0.5 | 0.1 | 0.1 | · | 0.1 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -35.1 | · | -31.5 | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-339M | $-103M | · | $-232M | $-133M | $-130M | · | $-145M | $-135M | $-121M | · | $-104M | $-92M | $-85M | · | $-76M | |
| Market Cap | $1.92B | $746M | · | $550M | $262M | $266M | · | $431M | $413M | $569M | · | · | · | · | · | · | |
| Enterprise Value | $1.54B | $331M | · | $395M | $71M | $36M | · | $252M | · | · | · | · | · | · | · | · | |
| P/E | -3.5 | -2.3 | · | -2.2 | -1.6 | -1.5 | · | -2.7 | -0.0 | -0.0 | · | -0.0 | -0.0 | -5.0 | · | -5.9 | |
| P/B | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Tangible Book | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Cash Flow | · | -15.6 | · | · | · | -5.8 | · | · | · | -27.3 | · | · | · | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -27.3 | · | · | · | · | · | · | |
| EV / EBITDA | -29.4 | -7.7 | · | -9.8 | -1.7 | -0.7 | · | -5.3 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -28.5% | -43.2% | · | -46.2% | -63.2% | -66.8% | · | -37.1% | -10294.4% | -7473.4% | · | -8401.0% | -7506.0% | -20.1% | · | -16.9% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utile netto | $-288M | $-155M | $-118M | $-92M | $-72M |
| EPS Diluito | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | -0.6 | 0.2 | — | — | — |
| Rapporto corrente | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 |
| Quick Ratio | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | — | $-119M | $-97M | $-106M | $-68M |
Ultime notizie Notizie recenti che menzionano questa società
- La FDA concede la revisione accelerata e la designazione CNPV a Compass Pathways (CMPS) per il trattamento della TRD
- Trump Invia le Azioni di Compass Pathways alle Stelle mentre Appoggia le Sostanze Psichedeliche. Dovresti Comprare CMPS Ora?
- Perché il titolo di Compass Pathways è salito del 40% oggi
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 251 filer · $1.3B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 66 (+6 vs trimestre precedente) | 30 (+7 vs trimestre precedente) | 77 (+3 vs trimestre precedente) | 53 (+26 vs trimestre precedente) | -2.0M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Deep Track Capital, LP | $172.085.168 | 12.161.496 | 13,73% | Azioni |
| RTW INVESTMENTS, LP | $151.418.782 | 10.700.974 | 12,08% | Azioni |
| BIT Capital GmbH | $89.835.478 | 6.348.797 | 7,17% | Azioni |
| TANG CAPITAL MANAGEMENT LLC | $70.750.000 | 5.000.000 | 5,65% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $63.257.363 | 4.470.485 | 5,05% | Azioni |
| ARK Investment Management LLC | $48.845.310 | 3.451.965 | 3,90% | Azioni |
| Point72 Asset Management, L.P. | $37.085.424 | 2.620.878 | 2,96% | Azioni |
| Logos Global Management LP | $31.837.500 | 2.250.000 | 2,54% | Azioni |
| Eagle Health Investments LP | $29.155.042 | 2.060.427 | 2,33% | Azioni |
| DAFNA Capital Management LLC | $28.469.121 | 2.011.952 | 2,27% | Azioni |
| BANK OF AMERICA CORP /DE/ | $28.339.691 | 2.002.805 | 2,26% | Azioni |
| Caption Management, LLC | $27.544.390 | 1.946.600 | 2,20% | Opzione Call |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $26.855.285 | 1.897.900 | 2,14% | Opzione Call |
| NEXTBio Capital Management LP | $25.126.990 | 1.775.759 | 2,00% | Azioni |
| MARSHALL WACE, LLP | $20.935.350 | 1.479.530 | 1,67% | Azioni |
| Aisling Capital Management LP | $20.267.554 | 1.432.336 | 1,62% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $20.261.229 | 1.431.889 | 1,62% | Azioni |
| Candriam S.C.A. | $18.013.686 | 1.274.278 | 1,44% | Azioni |
| Woodline Partners LP | $15.366.957 | 1.086.004 | 1,23% | Azioni |
| Jefferies Financial Group Inc. | $14.070.661 | 994.393 | 1,12% | Azioni |
| Trexquant Investment LP | $12.171.236 | 860.158 | 0,97% | Azioni |
| Kalehua Capital Management LLC | $11.598.642 | 819.692 | 0,93% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $10.909.466 | 770.987 | 0,87% | Azioni |
| Caption Management, LLC | $10.699.041 | 756.116 | 0,85% | Azioni |
| Eversept Partners, LP | $9.520.474 | 672.825 | 0,76% | Azioni |
| Propel Bio Management, LLC | $8.109.167 | 573.086 | 0,65% | Azioni |
| Creek Drive Management Group LLC | $8.093.800 | 572.000 | 0,65% | Azioni |
| Occam Crest Management LP | $7.739.000 | 710.000 | 0,62% | Azioni |
| CITADEL ADVISORS LLC | $7.567.420 | 534.800 | 0,60% | Opzione Call |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.140.090 | 504.600 | 0,57% | Opzione Put |
| SILVERARC CAPITAL MANAGEMENT, LLC | $7.122.855 | 503.382 | 0,57% | Azioni |
| JANE STREET GROUP, LLC | $7.075.821 | 500.058 | 0,56% | Azioni |
| Qube Research & Technologies Ltd | $7.070.415 | 499.676 | 0,56% | Azioni |
| Walleye Capital LLC | $6.893.385 | 487.165 | 0,55% | Azioni |
| Ensign Peak Advisors, Inc | $6.716.340 | 474.653 | 0,54% | Azioni |
| Blue Owl Capital Holdings LP | $6.367.500 | 450.000 | 0,51% | Azioni |
| AdvisorShares Investments LLC | $5.962.060 | 421.347 | 0,48% | Azioni |
| CITADEL ADVISORS LLC | $5.952.679 | 420.684 | 0,47% | Azioni |
| TWO SIGMA ADVISERS, LP | $5.909.850 | 856.500 | 0,47% | Azioni |
| GOLDMAN SACHS GROUP INC | $5.540.956 | 391.587 | 0,44% | Azioni |
| HighVista Strategies LLC | $5.251.349 | 371.120 | 0,42% | Azioni |
| Legal & General Group Plc | $4.700.154 | 332.206 | 0,38% | Azioni |
| Sumitomo Mitsui Trust Group, Inc. | $4.573.407 | 323.209 | 0,36% | Azioni |
| Amova Asset Management Americas, Inc. | $4.517.334 | 319.472 | 0,36% | Azioni |
| Squadron Capital Management LLC | $4.315.750 | 305.000 | 0,34% | Opzione Call |
| Affinity Asset Advisors, LLC | $4.261.739 | 301.183 | 0,34% | Azioni |
| SEVEN GRAND MANAGERS, LLC | $4.245.000 | 300.000 | 0,34% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.245.000 | 300.000 | 0,34% | Azioni |
| Squadron Capital Management LLC | $4.245.000 | 300.000 | 0,34% | Azioni |
| AMERIPRISE FINANCIAL INC | $4.081.271 | 288.429 | 0,33% | Azioni |
| JANE STREET GROUP, LLC | $4.079.445 | 288.300 | 0,33% | Opzione Call |
| STEMPOINT CAPITAL LP | $4.029.481 | 284.769 | 0,32% | Azioni |
| TORONTO DOMINION BANK | $3.930.233 | 277.755 | 0,31% | Azioni |
| ROYCE & ASSOCIATES LP | $3.778.885 | 267.059 | 0,30% | Azioni |
| PFM Health Sciences, LP | $3.503.384 | 247.589 | 0,28% | Azioni |
| D. E. Shaw & Co., Inc. | $3.408.367 | 240.874 | 0,27% | Azioni |
| Brown University | $3.030.930 | 214.200 | 0,24% | Azioni |
| MORGAN STANLEY | $2.973.693 | 210.155 | 0,24% | Azioni |
| Caption Management, LLC | $2.950.275 | 208.500 | 0,24% | Opzione Put |
| HEIGHTS CAPITAL MANAGEMENT, INC | $2.913.938 | 205.932 | 0,23% | Azioni |
| CITADEL ADVISORS LLC | $2.695.575 | 190.500 | 0,22% | Opzione Put |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | $2.481.528 | 175.373 | 0,20% | Azioni |
| Engineers Gate Manager LP | $2.432.343 | 171.897 | 0,19% | Azioni |
| Y-Intercept (Hong Kong) Ltd | $2.378.474 | 168.090 | 0,19% | Azioni |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | $2.122.500 | 150.000 | 0,17% | Azioni |
| Squarepoint Ops LLC | $1.962.195 | 138.671 | 0,16% | Azioni |
| Balyasny Asset Management L.P. | $1.959.492 | 138.480 | 0,16% | Azioni |
| ALPS ADVISORS INC | $1.930.937 | 136.462 | 0,15% | Azioni |
| Founders Fund VII Management, LLC | $1.924.272 | 278.880 | 0,15% | Azioni |
| K2 PRINCIPAL FUND, L.P. | $1.911.665 | 135.100 | 0,15% | Azioni |
| WELLS FARGO & COMPANY/MN | $1.897.246 | 134.081 | 0,15% | Azioni |
| CenterBook Partners LP | $1.777.155 | 125.594 | 0,14% | Azioni |
| Creek Drive Management Group LLC | $1.698.000 | 120.000 | 0,14% | Opzione Call |
| BANK OF MONTREAL /CAN/ | $1.686.991 | 119.222 | 0,13% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $1.639.118 | 115.839 | 0,13% | Azioni |
| Palo Alto Investors LP | $1.635.966 | 115.616 | 0,13% | Azioni |
| Simplify Asset Management Inc. | $1.617.076 | 114.281 | 0,13% | Azioni |
| LPL Financial LLC | $1.550.387 | 109.568 | 0,12% | Azioni |
| GROUP ONE TRADING LLC | $1.390.917 | 98.298 | 0,11% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $1.341.448 | 94.802 | 0,11% | Azioni |
| CreativeOne Wealth, LLC | $1.336.312 | 94.439 | 0,11% | Azioni |
| STABLEFORD CAPITAL II LLC | $1.300.003 | 91.873 | 0,10% | Azioni |
| STATE STREET CORP | $1.150.098 | 81.279 | 0,09% | Azioni |
| Lion Point Capital, LP | $1.132.000 | 80.000 | 0,09% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $1.063.896 | 75.187 | 0,08% | Azioni |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $1.016.635 | 71.847 | 0,08% | Azioni |
| DLD Asset Management, LP | $990.500 | 70.000 | 0,08% | Opzione Put |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $941.852 | 66.562 | 0,08% | Azioni |
| Aquatic Capital Management LLC | $922.297 | 65.180 | 0,07% | Azioni |
| JANE STREET GROUP, LLC | $915.505 | 64.700 | 0,07% | Opzione Put |
| Dorsey Wright & Associates | $883.653 | 62.449 | 0,07% | Azioni |
| Campbell & CO Investment Adviser LLC | $874.696 | 61.816 | 0,07% | Azioni |
| STIFEL FINANCIAL CORP | $855.639 | 60.469 | 0,07% | Azioni |
| Intellectus Partners, LLC | $841.925 | 59.500 | 0,07% | Azioni |
| DCF Advisers, LLC | $767.638 | 54.250 | 0,06% | Azioni |
| CIBC WORLD MARKET INC. | $737.357 | 52.110 | 0,06% | Azioni |
| NATIONAL BANK OF CANADA /FI/ | $731.420 | 51.727 | 0,06% | Azioni |
| FLAX POND CAPITAL, LLC | $728.951 | 51.516 | 0,06% | Azioni |
| EXCHANGE TRADED CONCEPTS, LLC | $708.943 | 50.102 | 0,06% | Azioni |
| PEAK6 LLC | $707.500 | 50.000 | 0,06% | Opzione Call |
Insider aziendali 9 insider · 0 dirigenti · 0 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kabir Nath | — | 03 Agosto 2026 F | 361.028 | 0 | 0 | $0 |
| Robert Mcquade | — | 27 Maggio 2026 A | — | 0 | 0 | $0 |
| Kathleen Tregoning | — | 27 Maggio 2026 A | — | 0 | 0 | $0 |
| Daphne Karydas | — | 27 Maggio 2026 A | — | 0 | 0 | $0 |
| Justin D. Gover | — | 27 Maggio 2026 A | — | 0 | 0 | $0 |
| David Y Norton | — | 27 Maggio 2026 A | — | 0 | 0 | $0 |
| Wayne Joseph Riley | — | 27 Maggio 2026 A | — | 0 | 0 | $0 |
| Gino Santini | — | 27 Maggio 2026 A | — | 0 | 0 | $0 |
| Jeffrey M Jonas | — | 27 Maggio 2026 A | — | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| AtaiBeckley Inc. | 17 Febbraio 2026 | 4,96% | Modifica | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 6 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 2,43% | 3.316.076 NS | 30 Aprile 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,99% | 40.950 NS | 30 Aprile 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,12% | 7.246 SH | 08 Agosto 2026 | Giornaliero |
| IBB · iShares Trust | 0,11% | 797.974 SH | 08 Agosto 2026 | Giornaliero |
| BIB · ProShares Trust | 0,06% | 3.487 NS | 31 Maggio 2026 | N-PORT |
| APIE · Trust for Professional Managers | 0,03% | 21.455 NS | 31 Maggio 2026 | N-PORT |